









Markets
/
Stocks
/
nasdaq-ew
/

Edwards Lifesciences Corp

View Detailed Chart

79.330USD

+0.020+0.03%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

46.50BMarket Cap

11.12P/E TTM



Edwards Lifesciences Corp

79.330

+0.020+0.03%

Overview Company Financials

Financials

Intraday

30m

Today

+0.03%

5 Days

-0.84%

1 Month

+2.79%

6 Months

+9.50%

Year to Date

+7.16%

1 Year

+28.24%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 35 analysts

BUY

Current Rating

87.974

Target Price

10.92%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Edwards Lifesciences Corp

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

Danaher Corp

DHR

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(3)

Neutral(4)

Buy(6)

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.542

Buy

RSI(14)

56.446

Neutral

STOCH(KDJ)(9,3,3)

55.077

Neutral

ATR(14)

1.990

High Vlolatility

CCI(14)

41.015

Neutral

Williams %R

47.631

Neutral

TRIX(12,20)

0.133

Sell

StochRSI(14)

0.783

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

79.752

Sell

MA10

78.433

Buy

MA20

77.768

Buy

MA50

76.926

Buy

MA100

74.660

Buy

MA200

72.928

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.

Ticker SymbolEW

CompanyEdwards Lifesciences Corp

CEOMr. Bernard J. Zovighian

Websitehttps://www.edwards.com